https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-04-01 / J Cancer Res Ther 2006 Apr-Jun;2(2):41-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-04-01 / J Cancer Res Ther 2006 Apr-Jun;2(2):41-62006-04-01 00:00:002019-02-15 09:17:42Hyperthermia today: electric energy, a new opportunity in cancer treatment
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-04-01 / Expert Rev Vaccines 2006 Apr;5(2):233-47
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-04-01 / Expert Rev Vaccines 2006 Apr;5(2):233-472006-04-01 00:00:002019-02-15 09:00:02Sensitization of malignant glioma to chemotherapy through dendritic cell vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-04-01 / Int. J. Oncol. 2006 Apr;28(4):855-61
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-04-01 / Int. J. Oncol. 2006 Apr;28(4):855-612006-04-01 00:00:002019-02-15 08:32:40Immunotherapy for patients with acute myeloid leukemia using autologous dendritic cells generated from leukemic blasts
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-04-01 / Expert Rev Vaccines 2006 Apr;5(2):211-22
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-04-01 / Expert Rev Vaccines 2006 Apr;5(2):211-222006-04-01 00:00:002019-02-15 08:32:40Current progress in the development of a cell-based vaccine for the immunotherapy of acute myeloid leukemia
